Macrophage Activation Led Acute Heart Failure Managed Successfully with Immunosuppression

Macrophage Activation Led Acute Heart Failure Managed Successfully with Immunosuppression

Karan Seegobin,1 Muhamad Alhaj Moustafa,1 Umair Majeed,1 Jordan C Ray,2 Marwan Shaikh,1 Liuyan Jiang,3 Han W Tun1 1Department of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL, 32224, USA; 2Departmentof Cardio-Oncology, Mayo Clinic, Jacksonville, FL, 32224, USA; 3Department of Pathol...

Full description

Bibliographic Details
Main Authors:	Seegobin K, Alhaj Moustafa M, Majeed U, Ray JC, Shaikh M, Jiang L, Tun HW
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-12-01
Series:	Journal of Blood Medicine
Subjects:	macrophage activation syndrome mas macrophage activation like syndrome mals cytokine release storm crs reversible systolic heart failure immunosuppression
Online Access:	https://www.dovepress.com/macrophage-activation-led-acute-heart-failure-managed-successfully-wit-peer-reviewed-fulltext-article-JBM

Similar Items

Macrophage activation syndrome in systemic lupus erythematosus - a case report
by: Maciej Rogala, et al.
Published: (2023-08-01)

Advances in attractive therapeutic approach for macrophage activation syndrome in COVID-19
by: Shunyao Chen, et al.
Published: (2023-07-01)

Egyptian evidence-based consensus on clinical practice guidelines for the diagnosis and treat-to-target management of macrophage activation syndrome in children
by: H. Lotfy, et al.
Published: (2022-06-01)

Macrophage Polarization and Plasticity in Systemic Lupus Erythematosus
by: Mariame Mohamed Ahamada, et al.
Published: (2021-12-01)

Clinical case of hemophagocytic lymphohistiocytosis: rare or undiagnosed syndrome?
by: O. B. Yaremenko, et al.
Published: (2023-03-01)

High Ferritin in a Critically ill COVID-19 Patient: The Calm before Cytokine Storm
by: Safa Saki, et al.
Published: (2020-07-01)

Does early treatment of macrophage activation syndrome prevent fatal outcome in patients with severe systemic juvenile idiopathic arthritis?
by: Marzena Janczewska, et al.
Published: (2014-03-01)

Role of Distinct Macrophage Populations in the Development of Heart Failure in Macrophage Activation Syndrome
by: Jakub Kuna, et al.
Published: (2022-02-01)

Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis
by: Zhi-qiang Tu, et al.
Published: (2017-08-01)

Drugs for paediatric hyperinflammatory syndromes
by: Kam Lun Hon, et al.
Published: (2022-05-01)

Septic macrophages induce T cells immunosuppression in a cell-cell contact manner with the involvement of CR3
by: Shunwei Huang, et al.
Published: (2024-01-01)

Lytic viral replication and immunopathology in a cytomegalovirus-induced mouse model of secondary hemophagocytic lymphohistiocytosis
by: Ellen Brisse, et al.
Published: (2017-12-01)

Case Report: Secondary Hemophagocytic Lymphohistiocytosis (sHLH) and Candida auris Fungemia in Post-acute COVID-19 Syndrome: A Clinical Challenge
by: Sachin Gautam, et al.
Published: (2022-06-01)

Editorial: Macrophage activation syndrome in children in the era of COVID-19
by: Oksana Boyarchuk, et al.
Published: (2023-06-01)

Macrophage activation syndrome in adults: Characteristics, outcomes, and therapeutic effectiveness of etoposide-based regimen
by: Lingbo He, et al.
Published: (2022-09-01)

A Rare STXBP2 Mutation in Severe COVID-19 and Secondary Cytokine Storm Syndrome
by: Daniel D. Reiff, et al.
Published: (2022-01-01)

Continuous IV infusion of anakinra
by: Brittney N. Saunders, et al.
Published: (2023-05-01)

Glomerular lipidosis as a feature of renal-limited macrophage activation syndrome in a transplanted kidney: a case report
by: Kentaro Sugisaki, et al.
Published: (2023-11-01)

A rare case of coronary artery complication in a child with systemic juvenile idiopathic arthritis and macrophage activation syndrome: case report and literature review
by: Lian Zhang, et al.
Published: (2024-01-01)

Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP)
by: Robert David Sandler, et al.
Published: (2020-03-01)

Elevated monocyte HLA-DR in pediatric secondary hemophagocytic lymphohistiocytosis: a retrospective study
by: Sylvain Raimbault, et al.
Published: (2023-11-01)

Immunosuppression-associated posterior reversible encephalopathy syndrome in an acute leukemia case
by: Umit Y. Malkan, et al.
Published: (2018-11-01)

Differential Diagnosis of Hyperferritinemia in Critically Ill Patients
by: Friederike S. Schuster, et al.
Published: (2022-12-01)

Presentation of hemophagocytic lymphohistiocytosis due to a novel MUNC 13–4 mutation masked by partial therapeutic immunosuppression
by: Garrett Jackie P-D, et al.
Published: (2012-05-01)

Systemic Juvenile Idiopathic Arthritis and Secondary Macrophage Activation Syndrome in Latvia from 2009 to 2020: A Nationwide Retrospective Study
by: Kristīne Lukjanoviča, et al.
Published: (2023-04-01)

High Mortality of HLH in ICU Regardless Etiology or Treatment
by: Amandine Bichon, et al.
Published: (2021-10-01)

Induction of Live Cell Phagocytosis by a Specific Combination of Inflammatory Stimuli
by: Takamasa Ishidome, et al.
Published: (2017-08-01)

Acute Heart Failure in the Course of Macrophage Activation Syndrome Due to Newly Diagnosed Systemic Lupus Erythematosus: Case Presentation and Literature Review
by: Jakub Kuna, et al.
Published: (2024-02-01)

Central nervous system involvement and thrombocytopenia as predictors of mortality in children with hemophagocytic lymphohistiocytosis
by: Saralee Harnchoowong, et al.
Published: (2022-09-01)

The Immunology of Macrophage Activation Syndrome
by: Courtney B. Crayne, et al.
Published: (2019-02-01)

Subversion of infiltrating prostate macrophages to a mixed immunosuppressive tumor‐associated macrophage phenotype
by: Clovis Boibessot, et al.
Published: (2022-01-01)

Sturge–Weber syndrome in childhood lupus complicated by macrophage activation syndrome
by: Manisha Jethwa, et al.
Published: (2023-01-01)

Subcutaneous panniculitis-like T-cell lymphoma with macrophage activation syndrome treated by cyclosporine and prednisolone
by: Dinesh P Asati, et al.
Published: (2016-01-01)

The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment
by: Lunxu Li, et al.
Published: (2023-05-01)

Could Metrnl be a New Biomarker to Predict the Development of Macrophage Activation Syndrome in COVID-19 Patients?
by: Dursun Erol AFŞİN, et al.
Published: (2023-03-01)

Specialized Pro-Resolving Mediators as Potential Regulators of Inflammatory Macrophage Responses in COVID-19
by: Maria G. Balta, et al.
Published: (2021-02-01)

Macrophage activation syndrome associated with systemic lupus erythematosus treated successfully with the combination of steroid pulse, immunoglobulin and tacrolimus
by: Aoyama-Maeda Natsuki, et al.
Published: (2018-06-01)

The Role of Myeloid Cells in GBM Immunosuppression
by: Ya-Jui Lin, et al.
Published: (2022-05-01)

Oral Etoposide for Dengue Induced Haemophagocytic Lymphohistiocytosis Presented as Acute Liver Failure
by: Bharat Patodiya, et al.
Published: (2022-09-01)

Children with Kawasaki disease or Kawasaki-like syndrome (MIS-C/PIMS) at the time of COVID-19: are they all the same? Case series and literature review
by: A. Marino, et al.
Published: (2021-04-01)